Recital 208, Decision_act (EU) 2018/9019

In forcesince 29 Oct 2018

For the above reasons, the Commission has decided not to oppose the notified

operation as modified by the commitments and to declare it compatible with the internal market, subject to full compliance with the conditions in Section B as well as the Schedule of the Final Commitments annexed to the present decision and with the obligations contained in the other sections of the said commitments.

This Decision is adopted in application of Article 6(1)(b) in conjunction with Article 6(2) of the Merger Regulation.

For the Commission (Signed) Margrethe VESTAGER Member of the Commission 19 October 2018 Case M.9019 – MARS / ANICURA COMMITMENTS TO THE EUROPEAN COMMISSION Pursuant to Article 6(2) of Council Regulation (EC) No 139/2004 (the Merger Regulation), Mars, Incorporated (Mars) hereby enters into the following Commitments (the Commitments) vis-à-vis the European Commission (the Commission) with a view to rendering its proposed acquisition of AniCura TC AB (AniCura) (the Concentration) compatible with the internal market and the functioning of the EEA Agreement.

This text shall be interpreted in light of the Commission’s decision pursuant to Article 6(1)(b) of the Merger Regulation to declare the Concentration compatible with the internal market and the functioning of the EEA Agreement (the Decision), in the general framework of European Union law, in particular in light of the Merger Regulation, and by reference to the Commission Notice on remedies acceptable under Council Regulation (EC) No 139/2004 and under Commission Regulation (EC) No 802/2004 (the Remedies Notice).